LINDEINDIA - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.6
| Stock Code | LINDEINDIA | Market Cap | 61,522 Cr. | Current Price | 7,208 ₹ | High / Low | 7,870 ₹ |
| Stock P/E | 105 | Book Value | 463 ₹ | Dividend Yield | 0.06 % | ROCE | 16.9 % |
| ROE | 12.3 % | Face Value | 10.0 ₹ | DMA 50 | 6,540 ₹ | DMA 200 | 6,370 ₹ |
| Chg in FII Hold | -0.32 % | Chg in DII Hold | 0.20 % | PAT Qtr | 192 Cr. | PAT Prev Qtr | 169 Cr. |
| RSI | 63.5 | MACD | 207 | Volume | 53,669 | Avg Vol 1Wk | 1,00,721 |
| Low price | 5,202 ₹ | High price | 7,870 ₹ | PEG Ratio | 7.65 | Debt to equity | 0.02 |
| 52w Index | 75.2 % | Qtr Profit Var | 68.1 % | EPS | 68.4 ₹ | Industry PE | 29.6 |
📊 Financial Overview
- Revenue & Profitability: PAT improved from 169 Cr. to 192 Cr. QoQ, showing healthy growth. EPS at 68.4 ₹ is solid but modest relative to valuation.
- Margins & Returns: ROE at 12.3% and ROCE at 16.9% are decent, reflecting moderate efficiency.
- Debt & Liquidity: Debt-to-equity ratio of 0.02 indicates negligible leverage, enhancing financial stability.
- Cash Flow: Strong profitability supports reinvestment capacity, though growth is priced aggressively.
💹 Valuation Metrics
- P/E Ratio: 105 vs Industry PE of 29.6 → Extremely overvalued.
- P/B Ratio: ~15.6 (Price 7,208 ₹ / Book Value 463 ₹) → Expensive relative to assets.
- PEG Ratio: 7.65 → Indicates growth is priced at a steep premium.
- Intrinsic Value: Current price appears significantly above fair value zone.
🏢 Business Model & Competitive Advantage
Linde India operates in industrial gases and engineering solutions, serving diverse industries including healthcare, manufacturing, and energy. Its global parentage, scale, and technological expertise provide a competitive edge. Demand drivers remain strong, but valuations are stretched relative to fundamentals.
📈 Entry Zone & Long-Term Guidance
Technically, RSI at 63.5 and positive MACD suggest bullish momentum. However, valuations are overheated. A better entry zone would be closer to 6,200–6,400 ₹ (near 200 DMA). Long-term holding is advisable only if earnings growth sustains and valuation multiples normalize.
✅ Positive
- Negligible debt (D/E 0.02).
- Strong global brand and diversified industrial demand.
- Quarterly PAT growth from 169 Cr. to 192 Cr.
⚠️ Limitation
- Extremely high P/E (105) and P/B (~15.6).
- PEG ratio of 7.65 indicates expensive growth pricing.
- ROE and ROCE moderate compared to valuation multiples.
📉 Company Negative News
- FII holdings decreased (-0.32%), showing reduced foreign confidence.
- Valuation significantly above industry average.
📈 Company Positive News
- Quarterly PAT improved QoQ.
- DII holdings increased (+0.20%), signaling some domestic support.
🏭 Industry
The industrial gases sector benefits from strong demand across healthcare, manufacturing, and energy. Industry PE at 29.6 highlights Linde India’s premium valuation. Global parentage and technology leadership provide resilience, but cyclical demand and competition remain factors.
🔎 Conclusion
Linde India is fundamentally strong with negligible debt and steady profit growth, but valuations are extremely stretched. While momentum is positive, investors should be cautious. Accumulation is advisable only near 6,200–6,400 ₹ for long-term holding, contingent on sustained earnings growth and normalization of valuation multiples.